前立腺がん治療の世界市場（～2026年）

• 英文タイトル：Global Prostate Cancer Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04391
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は前立腺がん治療のグローバル市場について調査・分析したレポートです。種類別（生物学的療法、化学療法）市場規模、用途別（病院、研究機関、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別前立腺がん治療の競争状況、市場シェア
・世界の前立腺がん治療市場：種類別市場規模 2015年-2020年（生物学的療法、化学療法）
・世界の前立腺がん治療市場：種類別市場規模予測 2021年-2026年（生物学的療法、化学療法）
・世界の前立腺がん治療市場：用途別市場規模 2015年-2020年（病院、研究機関、クリニック）
・世界の前立腺がん治療市場：用途別市場規模予測 2021年-2026年（病院、研究機関、クリニック）
・北米の前立腺がん治療市場分析：米国、カナダ
・ヨーロッパの前立腺がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの前立腺がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の前立腺がん治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの前立腺がん治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Tolmar、Astellas Pharma、AstraZeneca、Ferring Pharmaceuticals、Johnson & Johnson、Abbott、Sanofi、Ipsen、Novartis、Bayer
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

Market Analysis and Insights: Global Prostate Cancer Treatment Market
The global Prostate Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Prostate Cancer Treatment Scope and Market Size
Prostate Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer

Market segment by Type, the product can be split into
Biological Therapy
Chemotherapy
Market segment by Application, split into
Hospital
Research Institution
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biological Therapy
1.4.3 Chemotherapy
1.5 Market by Application
1.5.1 Global Prostate Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Research Institution
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Treatment Market Perspective (2015-2026)
2.2 Global Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Prostate Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Treatment Players by Market Size
3.1.1 Global Top Prostate Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Treatment Market Concentration Ratio
3.2.1 Global Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Revenue in 2019
3.3 Prostate Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Treatment Product Solution and Service
3.5 Date of Enter into Prostate Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Prostate Cancer Treatment Market Size (2015-2020)
6.2 Prostate Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Prostate Cancer Treatment Market Size (2015-2020)
7.2 Prostate Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Prostate Cancer Treatment Market Size (2015-2020)
8.2 Prostate Cancer Treatment Key Players in China (2019-2020)
8.3 China Prostate Cancer Treatment Market Size by Type (2015-2020)
8.4 China Prostate Cancer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Prostate Cancer Treatment Market Size (2015-2020)
9.2 Prostate Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Treatment Market Size (2015-2020)
10.2 Prostate Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Prostate Cancer Treatment Market Size (2015-2020)
11.2 Prostate Cancer Treatment Key Players in India (2019-2020)
11.3 India Prostate Cancer Treatment Market Size by Type (2015-2020)
11.4 India Prostate Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Prostate Cancer Treatment Market Size (2015-2020)
12.2 Prostate Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Tolmar
13.1.1 Tolmar Company Details
13.1.2 Tolmar Business Overview
13.1.3 Tolmar Prostate Cancer Treatment Introduction
13.1.4 Tolmar Revenue in Prostate Cancer Treatment Business (2015-2020))
13.1.5 Tolmar Recent Development
13.2 Astellas Pharma
13.2.1 Astellas Pharma Company Details
13.2.2 Astellas Pharma Business Overview
13.2.3 Astellas Pharma Prostate Cancer Treatment Introduction
13.2.4 Astellas Pharma Revenue in Prostate Cancer Treatment Business (2015-2020)
13.2.5 Astellas Pharma Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Prostate Cancer Treatment Introduction
13.3.4 AstraZeneca Revenue in Prostate Cancer Treatment Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Ferring Pharmaceuticals
13.4.1 Ferring Pharmaceuticals Company Details
13.4.2 Ferring Pharmaceuticals Business Overview
13.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Introduction
13.4.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2015-2020)
13.4.5 Ferring Pharmaceuticals Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Prostate Cancer Treatment Introduction
13.5.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Abbott
13.6.1 Abbott Company Details
13.6.2 Abbott Business Overview
13.6.3 Abbott Prostate Cancer Treatment Introduction
13.6.4 Abbott Revenue in Prostate Cancer Treatment Business (2015-2020)
13.6.5 Abbott Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Prostate Cancer Treatment Introduction
13.7.4 Sanofi Revenue in Prostate Cancer Treatment Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Ipsen
13.8.1 Ipsen Company Details
13.8.2 Ipsen Business Overview
13.8.3 Ipsen Prostate Cancer Treatment Introduction
13.8.4 Ipsen Revenue in Prostate Cancer Treatment Business (2015-2020)
13.8.5 Ipsen Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis Prostate Cancer Treatment Introduction
13.9.4 Novartis Revenue in Prostate Cancer Treatment Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Bayer
13.10.1 Bayer Company Details
13.10.2 Bayer Business Overview
13.10.3 Bayer Prostate Cancer Treatment Introduction
13.10.4 Bayer Revenue in Prostate Cancer Treatment Business (2015-2020)
13.10.5 Bayer Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Prostate Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Treatment Revenue
Table 3. Ranking of Global Top Prostate Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biological Therapy
Table 6. Key Players of Chemotherapy
Table 7. Global Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Prostate Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Prostate Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Prostate Cancer Treatment Market Share by Regions (2015-2020)
Table 11. Global Prostate Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Prostate Cancer Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Prostate Cancer Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Prostate Cancer Treatment Players
Table 18. Global Prostate Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Prostate Cancer Treatment Market Share by Players (2015-2020)
Table 20. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment as of 2019)
Table 21. Global Prostate Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prostate Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Prostate Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Prostate Cancer Treatment Market Size Share by Type (2015-2020)
Table 28. Global Prostate Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Prostate Cancer Treatment Market Size Share by Application (2015-2020)
Table 30. Global Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Prostate Cancer Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 34. North America Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 36. North America Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 40. Europe Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 42. Europe Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 46. China Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 48. China Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 52. Japan Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 54. Japan Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 58. Southeast Asia Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 64. India Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 66. India Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Prostate Cancer Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Prostate Cancer Treatment Market Share (2019-2020)
Table 70. Central & South America Prostate Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Prostate Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 74. Tolmar Company Details
Table 75. Tolmar Business Overview
Table 76. Tolmar Product
Table 77. Tolmar Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 78. Tolmar Recent Development
Table 79. Astellas Pharma Company Details
Table 80. Astellas Pharma Business Overview
Table 81. Astellas Pharma Product
Table 82. Astellas Pharma Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 83. Astellas Pharma Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Product
Table 87. AstraZeneca Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 88. AstraZeneca Recent Development
Table 89. Ferring Pharmaceuticals Company Details
Table 90. Ferring Pharmaceuticals Business Overview
Table 91. Ferring Pharmaceuticals Product
Table 92. Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 93. Ferring Pharmaceuticals Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 98. Johnson & Johnson Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. Ipsen Business Overview
Table 110. Ipsen Product
Table 111. Ipsen Company Details
Table 112. Ipsen Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 113. Ipsen Recent Development
Table 114. Novartis Company Details
Table 115. Novartis Business Overview
Table 116. Novartis Product
Table 117. Novartis Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 118. Novartis Recent Development
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Product
Table 122. Bayer Revenue in Prostate Cancer Treatment Business (2015-2020) (Million US$)
Table 123. Bayer Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Biological Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Prostate Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Research Institution Case Studies
Figure 7. Clinic Case Studies
Figure 8. Prostate Cancer Treatment Report Years Considered
Figure 9. Global Prostate Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Prostate Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Prostate Cancer Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Prostate Cancer Treatment Market Share by Players in 2019
Figure 14. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Revenue in 2019
Figure 16. North America Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Prostate Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

前立腺がん診断・治療の世界市場（～2026年）

Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04386 2020年11月20日 133Pages
当調査資料は前立腺がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（前立腺特異抗原検査（PSA）、直腸指診（DRE））市場規模、用途別（病院、診断クリニック、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

前立腺がんの世界市場（～2026年）

Global Prostate Cancer Market Size, Status and Forecast 2020-2026
MRC2-11QY04387 2020年11月20日 91Pages
当調査資料は前立腺がんのグローバル市場について調査・分析したレポートです。種類別（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん）市場規模、用途別（化学療法、ホルモン療法、標的療法、免疫療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

去勢抵抗性前立腺がん治療の世界市場（～2026年）

Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11289 2020年11月25日 97Pages
当調査資料は去勢抵抗性前立腺がん治療のグローバル市場について調査・分析したレポートです。種類別（ホルモン療法、抗アンドロゲン追加、抗アンドロゲン中止、エストロゲン、化学療法、放射線療法、その他）市場規模、用途別（病院、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

ホルモン抵抗性前立腺がんの世界市場（～2026年）

Global Hormone Refractory Prostate Cancer Market Size, Status and Forecast 2020-2026
MRC2-11QY12225 2020年11月25日 95Pages
当調査資料はホルモン抵抗性前立腺がんのグローバル市場について調査・分析したレポートです。種類別（化学療法、ホルモン療法、免疫療法、放射線療法、外科）市場規模、用途別（病院、外来手術センター、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

前立腺がん治療薬の世界市場（～2026年）

Global Prostate Cancer Medicine Market Size, Status and Forecast 2020-2026
MRC2-11QY04388 2020年11月20日 91Pages
当調査資料は前立腺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬）市場規模、用途別（病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

前立腺がんバイオマーカーの世界市場（～2026年）

Global Prostate Cancer Biomarker Market Size, Status and Forecast 2020-2026
MRC2-11QY04385 2020年11月20日 92Pages
当調査資料は前立腺がんバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（尿、血液、血清）市場規模、用途別（病院、診療所、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

非血液がん治療の世界市場（～2026年）

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04000 2020年11月20日 97Pages
当調査資料は非血液がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線療法、その他）市場規模、用途別（病院、腫瘍治療センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

前立腺がんスクリーニングの世界市場（～2026年）

Global Prostate Cancer Screening Market Size, Status and Forecast 2020-2026
MRC2-11QY04389 2020年11月20日 93Pages
当調査資料は前立腺がんスクリーニングのグローバル市場について調査・分析したレポートです。種類別（身体検査、臨床検査、画像検査、グリーソンスコア、TNMスコア、遺伝子検査、直腸指診、生検）市場規模、用途別（病院、診療所、研究所、がん研究所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨ...

転移性がん治療の世界市場（～2026年）

Global Metastatic Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12665 2020年11月25日 91Pages
当調査資料は転移性がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

胆管癌治療の世界市場（～2026年）

Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11052 2020年11月25日 98Pages
当調査資料は胆管癌治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法、放射線療法、手術）市場規模、用途別（肝内胆管がん、肝外胆管がん）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…
前立腺がん診断・治療の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. Market An…
前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
前立腺がんバイオマーカーの世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…